FDA Adverse Event Other Summary report: N

ADVIA CENTAUR XP AFP ASSAY

MDR report key: 1461670 · Received August 27, 2009

Report

Report Number
1219913-2009-00086
Event Type
Other
Date Received
August 27, 2009
Date of Event
July 20, 2009
Report Date
August 4, 2009
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Product Code
LOK
PMA / PMN Number
P930036
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CAUSE FOR THE DISCORDANT LOW ADVIA CENTAUR AFP RESULTS IS UNK. AS STATED IN THE IFU: "USE AFP RESULTS ONLY AS PART OF THE OVERALL CLINICAL EVALUATION OF A PT. DO NOT USE AFP RESULTS AS THE ONLY CRITERION FOR DIAGNOSTICS." NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 1

DISCORDANT LOW ADVIA CENTAUR XP AFP RESULTS WERE OBTAINED BY THE CUSTOMER ON SIX PT SAMPLES. THE CUSTOMER RUNS ALL AFP TESTS IN DUPLICATE. PT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE REPORTED LOW DISCORDANT AFP RESULTS.

Additional Manufacturer Narrative · 2

THE CAUSE FOR THE DISCORDANT LOW ADVIA CENTAUR AFP RESULTS IS UNK. AS STATED IN THE IFU: "USE AFP RESULTS ONLY AS PART OF THE OVERALL CLINICAL EVALUATION OF A PT. DO NOT USE AFP RESULTS AS THE ONLY CRITERION FOR DIAGNOSTICS." NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 2

DISCORDANT LOW ADVIA CENTAUR XP AFP RESULTS WERE OBTAINED BY THE CUSTOMER ON SIX PT SAMPLES. THE CUSTOMER RUNS ALL AFP TESTS IN DUPLICATE. PT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE REPORTED LOW DISCORDANT AFP RESULTS.

Additional Manufacturer Narrative · 3

THE CAUSE FOR THE DISCORDANT LOW ADVIA CENTAUR AFP RESULTS IS UNK. AS STATED IN THE IFU: "USE AFP RESULTS ONLY AS PART OF THE OVERALL CLINICAL EVALUATION OF A PT. DO NOT USE AFP RESULTS AS THE ONLY CRITERION FOR DIAGNOSTICS." NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 3

DISCORDANT LOW ADVIA CENTAUR XP AFP RESULTS WERE OBTAINED BY THE CUSTOMER ON SIX PT SAMPLES. THE CUSTOMER RUNS ALL AFP TESTS IN DUPLICATE. PT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE REPORTED LOW DISCORDANT AFP RESULTS.

Additional Manufacturer Narrative · 4

THE CAUSE FOR THE DISCORDANT LOW ADVIA CENTAUR AFP RESULTS IS UNK. AS STATED IN THE IFU: "USE AFP RESULTS ONLY AS PART OF THE OVERALL CLINICAL EVALUATION OF A PT. DO NOT USE AFP RESULTS AS THE ONLY CRITERION FOR DIAGNOSTICS." NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 4

DISCORDANT LOW ADVIA CENTAUR XP AFP RESULTS WERE OBTAINED BY THE CUSTOMER ON SIX PT SAMPLES. THE CUSTOMER RUNS ALL AFP TESTS IN DUPLICATE. PT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE REPORTED LOW DISCORDANT AFP RESULTS.

Additional Manufacturer Narrative · 5

THE CAUSE FOR THE DISCORDANT LOW ADVIA CENTAUR AFP RESULTS IS UNK. AS STATED IN THE IFU: "USE AFP RESULTS ONLY AS PART OF THE OVERALL CLINICAL EVALUATION OF A PT. DO NOT USE AFP RESULTS AS THE ONLY CRITERION FOR DIAGNOSTICS." NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 5

DISCORDANT LOW ADVIA CENTAUR XP AFP RESULTS WERE OBTAINED BY THE CUSTOMER ON SIX PT SAMPLES. THE CUSTOMER RUNS ALL AFP TESTS IN DUPLICATE. PT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE REPORTED LOW DISCORDANT AFP RESULTS.

Additional Manufacturer Narrative · 6

THE CAUSE FOR THE DISCORDANT LOW ADVIA CENTAUR AFP RESULTS IS UNK. AS STATED IN THE IFU: "USE AFP RESULTS ONLY AS PART OF THE OVERALL CLINICAL EVALUATION OF A PT. DO NOT USE AFP RESULTS AS THE ONLY CRITERION FOR DIAGNOSTICS." NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 6

DISCORDANT LOW ADVIA CENTAUR XP AFP RESULTS WERE OBTAINED BY THE CUSTOMER ON SIX PT SAMPLES. THE CUSTOMER RUNS ALL AFP TESTS IN DUPLICATE. PT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE REPORTED LOW DISCORDANT AFP RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADVIA CENTAUR XP AFP ASSAY AFP IMMUNOASSAY LOK SIEMENS HEALTHCARE DIAGNOSTICS INC. NA 127

Patients

Seq Age Sex Outcome Treatment
1
2
3
4
5
6